For example, the augmentation of CSF receptor/ligand pairs CCL2/CXCL10, CXCR3/CCR5 and CCL3/CXCL10 in HIV/CM patients with neurological deterioration leads to the development of CM-IRIS after ART initiation [66]. This evidence concerns the gene CCL2 and cutaneous mastocytosis.